Exosens (EPA:EXENS)
France · Delayed Price · Currency is EUR 58.85
+1.65 (2.88%)
Aug 3, 2026, 11:44 AM CET
Exosens Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 68.81 | 68.62 | 117.16 | 15.46 | 28.96 |
Cash & Short-Term Investments | 68.81 | 68.62 | 117.16 | 15.46 | 28.96 |
Cash Growth | 0.28% | -41.43% | 657.94% | -46.61% | - |
Accounts Receivable | 76.01 | 73.13 | 70.98 | 69.19 | 32.68 |
Inventory | 123.26 | 105.09 | 93.02 | 78.54 | 55.66 |
Other Current Assets | 37.67 | 33.4 | 33.04 | 29.37 | 27.44 |
Total Current Assets | 305.75 | 280.23 | 314.2 | 192.71 | 144.74 |
Net Property, Plant & Equipment | 144.34 | 128.11 | 104.12 | 82.81 | 60.46 |
Other Intangible Assets | 197.34 | 225.8 | 204.93 | 202.35 | 181.09 |
Goodwill | 233.44 | 233.33 | 189.5 | 174.34 | 139.64 |
Long-Term Investments | 8.46 | 3.84 | 3.41 | 3.41 | 2.76 |
Other Long-Term Assets | 5.67 | 7.57 | 0.86 | 0.79 | 0.57 |
Total Assets | 894.99 | 878.88 | 817.01 | 656.41 | 529.25 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Accounts Payable | 35.63 | 31.2 | 26.03 | 32.3 | 22.89 |
Current Portion of Long-Term Debt | 0.28 | 0.49 | 2.45 | 7.03 | 5.37 |
Current Portion of Leases | 4.97 | 2.97 | 2.72 | 2.36 | 2.06 |
Other Current Liabilities | 89.08 | 79.04 | 75.77 | 68.55 | 42.12 |
Total Current Liabilities | 129.96 | 113.7 | 106.97 | 110.08 | 72.45 |
Long-Term Debt | 251.44 | 249.28 | 247.79 | 300.84 | 238.37 |
Long-Term Leases | 12.78 | 13.65 | 8.17 | 7.69 | 7.57 |
Other Long-Term Liabilities | 49.92 | 56.6 | 41.48 | 33.73 | 27.81 |
Total Long-Term Liabilities | 314.14 | 319.52 | 297.44 | 342.26 | 273.75 |
Total Liabilities | 444.1 | 433.23 | 404.41 | 452.35 | 346.2 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Common Stock | 21.65 | 21.65 | 21.58 | 1.95 | 1.94 |
Additional Paid-in Capital | 346.76 | 346.76 | 342.54 | 188.05 | 188.06 |
Retained Earnings | 82.47 | 77.24 | 48.48 | 14.07 | -6.95 |
Shareholders' Equity | 450.88 | 445.65 | 412.6 | 204.07 | 183.05 |
Total Liabilities & Equity | 894.99 | 878.88 | 817.01 | 656.41 | 529.25 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Total Debt | 269.47 | 266.39 | 261.14 | 317.92 | 253.37 |
Net Cash (Debt) | -200.66 | -197.77 | -143.98 | -302.47 | -224.42 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -3.97 | -3.90 | -3.45 | -9.95 | -7.38 |
Book Value | 450.88 | 445.65 | 412.6 | 204.07 | 183.05 |
Book Value Per Share | 8.92 | 8.79 | 9.89 | 6.72 | 6.02 |
Tangible Book Value | 20.11 | -13.48 | 18.18 | -172.63 | -137.68 |
Tangible Book Value Per Share | 0.40 | -0.27 | 0.44 | -5.68 | -4.53 |